What Is an INAD (Investigational New Animal Drug)?
Investigational New Animal Drug (INAD) is an important aspect in the pharmaceutical and veterinary regulatory environment that facilitates the transfer of innovative animal health products out of the laboratory into the market. An INAD is a regulatory filing by the U.S. Food and Drug Administration (FDA) (via the Center of Veterinary Medicine (CVM)) by which a company or sponsor is permitted to legally transport and test an unapproved new animal drug across state boundaries in order to conduct research.
What is RMP (Risk Management Plan)?
In the pharmaceutical industry, patient safety is a constant task that extends well beyond clinical development and initial marketing approval. Pharmacovigilance documentation that is arranged methodically and outlines how potential and identified risks of a medication are managed and controlled over the course of its lifecycle is called a Risk Management Plan (RMP).
What Is Clinical Data Management (CDM)?
In the pharmaceutical sector, Clinical Data Management (CDM) is crucial for guaranteeing that the data gathered during clinical trials is accurate, dependable, and compliant with regulatory requirements.
What is Regulatory Intelligence?
Regulatory Intelligence (RI) in the pharmaceutical sector is more than just monitoring the latest regulations. It’s about interpreting what those regulations mean, foreseeing changes, and applying that understanding to navigate drug development and compliance effectively.
Compliance Guidelines: Strengthening Regulatory Compliance with Masuu Global
In the modern dynamic regulatory environment, companies need to establish strong compliance policies to make sure that all the laws, industry standards, and internal policies are followed in a consistent way. Good regulatory compliance program will help decrease legal risks and will also create confidence with the stakeholders and regulatory bodies.